Forthcoming Titles
(PDF in this page may have not been proofed yet)



Markus Muschen, et al:
Tyrosine kinase signaling in hematologic malignancies. Am J Blood Res 2019;9(x):xx-xx.

Haifa Kathrin AI-Ali, et al: Kinetics of iron removal by phlebotomy in patients with iron overload after allogeneic hematopoietic
cell transplantation. Am J Blood Res 2019;9(x):xx-xx.

David M Goldenberg, et al: Bispecific antibodies in the therapy of hematological tumors. Am J Blood Res 2019;9(x):xx-xxx.

John C Byrd, et al: NF-κB regulation of Mcl-1 in B-cells.
Am J Blood Res 2019;9(x):xx-xx.

Anna Rita Migliaccio, et al: Role of the polymorphism of the glucocorticoid receptor in human stress erythropoiesis. Am J
Blood Res Am J Blood Res 2019;9(x):xx-xx.

Tom C Karagiannis, et al: Evaluation of combination therapies with chromatin modifying compounds and chemotherapeutic
agents in human leukemic cells. Am J Blood Res Am J Blood Res 2019;9(x):xx-xx.

Francesco Spina, et al: Review of Thiotepa-based conditioning in allogeneic transplantation. Am J Blood Res 2019;9(x):xx-xx.

Jian-Hua Feng, Xiao-Ping Guo, Yuan-Yuan Chen, Zhu-Jun Wang, Yu-Ping Cheng, Yong-Min Tang: Prognostic significance of
isocitrate dehydrogenase 1 (IDH1) mutations in acute myeloid leukemia: a meta-analysis. Am J Blood Res 2019;9(x):xx-xx.

Claude Perreault, et al: Mechanisms of graft-host tolerance. Am J Blood Res 2019;9(x):xx-xx.

Jatin J Shah, et al:  Current retreatment strategies in patients with multiple myeloma previously treated with Bortezomib or
Lenalidomide. Am J Blood Res 2019;9(x):xx-xx.

Gutian Xiao, et al: NF-kappaB in normal hematology and hematologic disorders. Am J Blood Res 2019;9(x):xx-xxx.

Atsushi Otani, et al: Bone marrow derived cells and neurodegenerative diseases. Am J Blood Res 2019;9(x):xx-xx.

Chengcheng Zhang, et al: Ex vivo expansion of mouse and human hematopoietic stem cells for transplantation. Am J Blood
Res 2019;9(x):xx-xx.

Michail Kotsyfakis, et al: 'The role of proteolysis regulation for feeding success of hematophagous arthropods. Am J Blood
Res 2019;9(x):xx-xx.

Ravi Vij, et al: Novel therapies for Multiple Myeloma. Am J Blood Res 2019;9(x):xx-xx.

Martin Ruthardt, et al: Class I and II mutations in leukemogenic transformation. Am J Blood Res 2019;9(x):xx-xx.

Sattva S Neelapu, et al: Vaccine therapy for lymphomas, a review. Am J Blood Res 2019;9(x):xx-xx.

Hwei-Fang Tien, et al: Risk stratification of patients with acute myeloid leukemia by integrating molecular gene mutations with
cytogenetics. Am J Blood Res 2019;9(x):xx-xx.

Stavropoulou V, Schwaller J. Mouse models of human leukemic disorders. Am J Blood Res 2019;9(x):xx-xx.

Antonio Pineda-Lucena, et al: Identifying early biomarkers of disease in hemato-oncology. Am J Blood Res 2019;9(x):xx-xx.

Bipin N. Savani, et al: Lymphocyte recovery in hematological malignancies: How and who will benefits from early lymphocyte
recovery and how do we get the best recovery? Am J Blood Res 2019;9(x):xx-xx.

Pavan Reddy, et al: Immmuno-biology of allogeneic BMT. Am J Blood Res 2019;9(x):xx-xx.

Jacques Ghysdael, et al: CA++, calcineurin, NFAT pathway in leukemia and lymphoma. Am J Blood Res 2019;9(x):xx-xx.

Anne Caignard, et al: Natural Killer cells and human tumors. Am J Blood Res 2019;9(x):xx-xx.

Cornelia Brunner, et al: Transcriptional regulation of granulopoiesis. Am J Blood Res 2019;9(x):xx-xx.

Charles H Lawrie, et al: Circulating miRNAs as non-invasive biomarkers in hematological malignancy. Am J Blood Res 201
6;
6(x):xx-xx..

Tamar Tadmor, et al: Gene therapy for Chronic Lymphocytic Leukemia (CLL). Am J Blood Res 2019;9(x):xx-xx.

Jian Hou, et al: Metabolism of thalidomide by cytochrome P450 is essential for its anti-myeloma effects. Am J Blood Res 201
6;
6(x):xx-xx..

Uri Rozovski, et al: Genetic anticipation in hematology, MRD in acute leukemia. Am J Blood Res 2019;9(x):xx-xx.

Hong Chang, et al: Targeting of p53 in hematological malignancies. Am J Blood Res 2019;9(x):xx-xx.

Uri Rozovski, et al: Increased incidence of red blood cell alloantibody formation in patients with myelodysplastic syndrome.  
Am J Blood Res 2019;9(x):xx-xx.

Chengyun Zheng, et al: Hematopoietic stem cells: immune privilege and extrinsic regulation of cell fates by the immune
system. Am J Blood Res 2019;9(x):xx-xx.

Andrew M. Evens, et al: Novel therapeutic options for the treatment of indolent lymphoma. Am J Blood Res 2019;9(x):xx-xx.

Simonetta Viviani, et al: Elevated serum TARC levels are associated with prognosis in Hodgkin's lymphoma. Am J Blood Res
2019;9(x):xx-xx.

Tamar Tadmor, et al: Update on the biology and therapy of Hairy cell leukemia. Am J Blood Res 2019;9(x):xx-xx.

Alessandro Isidori, et al: Hematopoietic stem and progenitor cell mobilization: from serendipity to targeted cell therapy. Am J
Blood Res 2019;9(x):xx-xx.

Damiano Rondelli, et al: Who's who in cross-talk between CD34+ cells and T cells in allogeneic stem cell transplantation. Am
J Blood Res 2019;9(x):xx-xx.

Muthu Veeraputhiran, et al: DRESS/ Autologous GVHD incidence and diagnoses among Myeloma patients. Am J Blood Res
2019;9(x):xx-xx.

Andrew M. Evens, et al: HBV reactivation in lymphoma: prognostic, diagnostic, and therapeutic considerations. Am J Blood
Res 2019;9(x):xx-xx.

Jessica Ann Shafer, et al: Immunotherapy, is this a cancer stem cell directed therapy? Am J Blood Res 2019;9(x):xx-xx.

Volker Blank, et al: Regulation of erythropoiesis, a review. Am J Blood Res 2019;9(x):xx-xx.

Erika J. Mancini, et al: Transcriptional networks regulating haematopoiesis: a structural perspective. Am J Blood Res 201
6;6
(x):xx-xx..

Daolin Tang, et al: Role of WAVE1 in leukemia. Am J Blood Res 2019;9(x):xx-xx.

Volker Blank, et al: Novel regulators of erythroid differentiation. Am J Blood Res 2019;9(x):xx-xx.

Stefano Molica, et al: New and old prognostic marker in CLL. Am J Blood Res 2019;9(x):xx-xx.

Karen Pulford, et al: Cancer testis antigens and lymphoma - potential biomarkers and therapeutic targets. Am J Blood Res
2019;9(x):xx-xx.

Rudi W Hendriks, et al: Btk-mediated BCR signaling enhances lymphomagenesis in a mouse model for chronic lymphocytic
leukemia. Am J Blood Res 2019;9(x):xx-xx.

Jan A Burger, et al: The microenvironment in CLL and other mature B cell malignancies: molecular cross talk and therapeutic
targets. Am J Blood Res 2019;9(x):xx-xx.

Anas Younes, et al: The lymphoma response criteria in the age of targeted therapy. Am J Blood Res 2019;9(x):xx-xx.

Kit-Fai Wong, et al: The promise and peril of blood cancer cytogenetics. Am J Blood Res 2019;9(x):xx-xx.

Peter Valent, et al: Where and when and where Not to use erythropoietin in clinical hematology and cancer patients: when the
logic comes to mind. Am J Blood Res 2019;9(x):xx-xx.

Roy F Chemaly, et al: Management of respiratory viral infections after HSCT. Am J Blood Res 2019;9(x):xx-xx.

Massimo Massaia, et al: Gammadelta T cells in hematology. Am J Blood Res 2019;9(x):xx-xx.

Kate Burbury, et al: Haemostatic dysfunction and cancer. Am J Blood Res 2019;9(x):xx-xx.

Shuki Mizutani, et al: RAS/MAPK abnormality and childhood disorder. Am J Blood Res 2019;9(x):xx-xx.

Hwei-Fang Tien, et al: Interaction of gene mutations in acute myeloid leukemia. Am J Blood Res 2019;9(x):xx-xx.

Tarik Möröy, et al: Transcription factors Gfi1 and Gfi1b control hematopoiesis and prevent emergence of leukemia and
lymphoma. Am J Blood Res 2019;9(x):xx-xx.

Dimitar Efremov, et al: Targeting B-cell receptor signaling in chronic lymphocytic leukemia. Am J Blood Res 2019;9(x):xx-xx.

Andrea la Sala , et al: Regulation of innate immunity by extracellular nucleotides. Am J Blood Res 2019;9(x):xx-xx.

Thiago Moreno L. Souza, et al: Is Influenza A virus found in the blood? Am J Blood Res 2019;9(x):xx-xx.

Thiago Moreno L. Souza, et al: Molecular aspects of HIV-1/HSV-1 coinfection. Am J Blood Res 2019;9(x):xx-xx.

Jeanette H.W. Leusen, et al: In vivo effectormechanisms of CD20 antibodies. Am J Blood Res 2019;9(x):xx-xx.

Yukiya Yamamoto, et al: Isolation of human monoclonal antibodies with antagonistic activities for FLT3 targeting therapy. Am
J Blood Res 2019;9(x):xx-xx.

Axel zur Hausen, et al: Polyomaviruses in the etiopathogenesis of Non Hogkin lymphomas. Am J Blood Res 2019;9(x):xx-xx.

Christian Straka, et al: G-CSF responsiveness as a predictor of infection following myelosuppressive chemotherapy. Am J
Blood Res 2019;9(x):xx-xx.

Vladimir Lj Lazarevic, et al: Alllogeneic stem cell transplantation on follicular lymphoma. Am J Blood Res 2019;9(x):xx-xx.

Vladimir Lj Lazarevic, et al: AML therapy in elderly. Am J Blood Res 2019;9(x):xx-xx.

Georg Stüssi, et al: Rituximab in the treatment of chronic GvHD. Am J Blood Res 2019;9(x):xx-xx.

Heyu Ni, et al: Fibronectin in thrombosis and hemostasis. Am J Blood Res 2019;9(x):xx-xx.

Xin Liu, et al: Epigenetic regulation as a novel target for large granular lymphocyte leukemia. Am J Blood Res 2019;9(x):xx-xx.

Hideaki Nakajima, et al: Role of transcription factors in normal and malignant hematopoiesis. Am J Blood Res 2019;9(x):xx-xx.

Tomas Stopka, et al: Tumor suppressor role of PU.1 in hematologic malignancies. Am J Blood Res 2019;9(x):xx-xx.

Michael R. Verneris, et al:  IL-22 producing cells in health and disease. Am J Blood Res 2019;9(x):xx-xx.

John Michael Pagel, et al: Conventional anti-CD45 radioimmunotherapy comparing 90Y or 177Lu for treatment of AML in a
syngeneic disseminated murine leukemia model. Am J Blood Res 2019;9(x):xx-xx.

Alexander Steinkasserer, et al: Modulation of autoimmunity and transplant rejection by soluble CD83. Am J Blood Res 201
6;6
(x):xx-xx..

Vivienne I Rebel, et al: The impact of aging on the bone marrow microenvironment. Am J Blood Res 2019;9(x):xx-xx.

Susan Chan, et al: Ikaros family members in hematopoiesis. Am J Blood Res 2019;9(x):xx-xx.

Nami McCarty, et al: Expression of drug transporters, ABCB1 and ABCC3, contributes drug resistance of mantle cell
lymphoma. Am J Blood Res 2019;9(x):xx-xx.

Hongbo Yu, et al: Detection of immune suppressive neutrophils in peripheral blood samples of cancer patients. Am J Blood
Res 2019;9(x):xx-xx.

Kumudha Balakrishnan, et al: BH3 mimetics in CLL. Am J Blood Res 2019;9(x):xx-xx.

Heather Landau, et al: The role of SCT in MM in the era of novel therapies. Am J Blood Res 2019;9(x):xx-xx.

Julia Kirshner, et al: The many faces of the multiple myeloma progenitor cell. Am J Blood Res 2019;9(x):xx-xx.

H Joachim Deeg, et al: MDS and the marrow microenvironment. Am J Blood Res 2019;9(x):xx-xx.

Steve A Maxwell, et al: Targeting Drug Resistance in B-Cell Lymphomas. Am J Blood Res 2019;9(x):xx-xx.

Sgixia Xu, et al: Micafungin and voriconazole for fungal infection prevention during hematopoietic cell transplantation: a meta-
analysis. Am J Blood Res 2019;9(x):xx-xx.

Idit Shachar, et al: Molecular mechanisms regulating B cell survival in health and disease. Am J Blood Res 2019;9(x):xx-xx.

Sumin Kang, et al: p90RSK2 signaling in FLT3-ITD associated myeloid transformation. Am J Blood Res 2019;9(x):xx-xx.

Giovanni D’Arena, et al: Regulatory T-cells in chronic lymphocytic leukemia: actor or innocent bystander? Am J Blood Res
2019;9(x):xx-xx.

Yasuhiro Oki, et al: Current treatment strategies for peripheral T-cell lymphoma. Am J Blood Res 2019;9(x):xx-xx.

Jason R Westin, et al: Is R-CHOP the optimal frontline therapy for diffuse large B-cell lymphoma. Am J Blood Res 2019;9(x):xx-
xx..

Ciro Roberto, et al: GATA1 Expression levels in peripheral blood of patients with essential thrombocytaemia: implication for
pathogenesis and treatment. Am J Blood Res 2019;9(x):xx-xx.

Bouthaina S Dabaja, et al: Mantle cell lymphoma and response to palliative radiation. Am J Blood Res 2019;9(x):xx-xx.

Maciej Machaczka, et al: Rare GBA1 mutations and their phenotypic presentation in patients with sporadic Gaucher disease
type 1. Am J Blood Res 2019;9(x):xx-xx.







(The journal is now accepting manuscript submissions. The first issue is planned for June, 2011 although earlier launching
is possible if enough great manuscripts are received. Please go to
Information for Authors to prepare your manuscript for
submission to American Journal of Blood Research.)
AJBR Copyright © 2011-present, All rights reserved. Published by e-Century Publishing Corporation, Madison, WI 53711, USA